| 0.4785 -0.081 (-14.4%) | 11-07 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 2.26 |
1-year : | 3.32 |
| Resists | First : | 1.93 |
Second : | 2.84 |
| Pivot price | 0.92 |
|||
| Supports | First : | 0.46 |
Second : | 0.38 |
| MAs | MA(5) : | 0.56 |
MA(20) : | 1.1 |
| MA(100) : | 2.26 |
MA(250) : | 19.1 |
|
| MACD | MACD : | -0.4 |
Signal : | -0.3 |
| %K %D | K(14,3) : | 3.5 |
D(3) : | 3.1  |
| RSI | RSI(14): 19.8 |
|||
| 52-week | High : | 144.35 | Low : | 0.1 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ NIVF ] has closed above bottom band by 12.2%. Bollinger Bands are 40.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 141 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 0.57 - 0.57 | 0.57 - 0.57 |
| Low: | 0.45 - 0.46 | 0.46 - 0.46 |
| Close: | 0.47 - 0.48 | 0.48 - 0.48 |
NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families. The firm offers in-vitro fertilization treatment service, comprising traditional IVF and egg donation, and surrogacy and ancillary caring services. The company is headquartered in Bangkok, Thailand.
Wed, 05 Nov 2025
NewGenIvf Group appointed as SAXA agent for gold-backed asset tokenization - TipRanks
Wed, 05 Nov 2025
NewGenIvf gets delisting notice from Nasdaq - MSN
Fri, 17 Oct 2025
What's Going On With NewGenIvf Shares Friday? - Benzinga
Fri, 10 Oct 2025
NewGenIVF Group Limited Receives Equity Research Coverage from Zacks Small-Cap Research - Quiver Quantitative
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Plans
|
|
| Shares Out | 2 (M) |
| Shares Float | 2 (M) |
| Held by Insiders | 1 (%) |
| Held by Institutions | 0.3 (%) |
| Shares Short | 320 (K) |
| Shares Short P.Month | 49 (K) |
| EPS | 28.68 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.3 |
| Profit Margin | 12.5 % |
| Operating Margin | -160.5 % |
| Return on Assets (ttm) | -31.4 % |
| Return on Equity (ttm) | 307 % |
| Qtrly Rev. Growth | -24.8 % |
| Gross Profit (p.s.) | 0.69 |
| Sales Per Share | 2.21 |
| EBITDA (p.s.) | -1.91 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -15 (M) |
| PE Ratio | 0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0.11 |
| Price to Sales | 0.21 |
| Price to Cash Flow | -0.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|